T2 BIOSYSTEMS INC (TTOO)
US89853L3024 - Common Stock
T2 Biosystems to Report First Quarter 2024 Financial Results and Business Updates on May 6, 2024
LEXINGTON, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and...
Tuesday's pre-market session: top gainers and losers
As we await the opening of the US market on Tuesday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
We're diving into the biggest pre-market stock movers that traders are going to want to keep an eye on for Tuesday morning!
Curious about the stocks that are showing activity after the closing bell on Friday?
Discover the top movers in Friday's after-hours session and stay informed about the post-market dynamics.
T2 Biosystems Shareholders Vote for CRG Debt Conversion into Equity
LEXINGTON, Mass., April 11, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and...
T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.
LEXINGTON, Mass., March 28, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and...
T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business Updates
Anticipates commercial launch of the T2Lyme Panel in the third quarter of 2024...
T2 Biosystems to Host Investor Call on March 20, 2024 to Unveil its T2Lyme Launch Plans and Provide Additional Business Updates
LEXINGTON, Mass., March 19, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing...
TTOO Stock: T2 Biosystems Has Until May 20 to Regain Nasdaq Compliance
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Shares of T2 Biosystems (NASDAQ:TTOO) stock are rising higher after the medical...
TTOO Stock: T2 Biosystems Has Until May 20 to Regain Nasdaq Compliance
TTOO stock is in the green after the company announced that it had received an extension to reach a $35 million market capitalization.
T2 Biosystems Receives Extension to Comply with Nasdaq Listing Requirement
LEXINGTON, Mass., March 12, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and...
T2 Biosystems says it achieved full year 2023 total revenue of $7.2M (NASDAQ:TTOO)
T2 Biosystems reports strong growth in total revenue for 2023, driven by sepsis and related product sales.
T2 Biosystems signs deal for conversion of $15M CRG term loan into equity (NASDAQ:TTOO)
T2 Biosystems signed an agreement with CRG Servicing to convert $15M of its loan into equity after stockholder approval.
T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2023 Financial Results
Advanced multiple new products and achieved record fourth quarter U.S. T2Bacteria Panel sales...
T2 Biosystems Announces Agreement with CRG for the Conversion of $15 Million of CRG Term Loan into Equity
LEXINGTON, Mass., Feb. 15, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and...
T2 Biosystems Announces Commercial Expansion Through Distributors in Europe and Asia
LEXINGTON, Mass., Feb. 15, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and...
T2 Biosystems Receives 510(K) Clearance for Its Bacteria Panel
TTOO stock is in the green after the company received FDA approval for an additional bacteria on its T2Bacteria Panel.
T2 Biosystems Receives FDA 510(k) Clearance for the Expanded T2Bacteria Panel
Increases number of bacteria species detected with addition of Acinetobacter baumannii...
T2 BioSystems stock: brace for TTOO volatility this week
T2 BioSystems (NASDAQ: TTOO) stock price has moved from one of the most popular names in Wall Street into a forgotten one. The shares have gone nowhere since October and are now sitting near their lowest level on record. They have plunged by over 93% from last year’s high of $70. T2 BioSystems earnings ahead […]
T2 Biosystems to Report Fourth Quarter and Full Year 2023 Financial Results and Business Updates on February 15, 2024
LEXINGTON, Mass., Feb. 07, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and...
U.S. Department of Health and Human Services and Steven and Alexandra Cohen Foundation Name T2 Biosystems a Phase 2 Winner in the LymeX Diagnostics Prize
LEXINGTON, Mass., Feb. 07, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens and...
T2 Biosystems Announces Participation in NIH-funded Antibacterial Resistance Leadership Group (ARLG) Pilot Study for Pneumonia Patients
LEXINGTON, Mass., Jan. 18, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and...
T2 Biosystems Announces FDA 510(k) Submission to Expand Use of the FDA-Cleared T2Candida Panel to Include Pediatric Testing
LEXINGTON, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and...
What’s going on with T2 Biosystems (TTOO) stock?
T2 BioSystems (NASDAQ: TTOO) stock price rose by more than 23% on Tuesday amid a short-squeeze and as some investors bought the dip. The shares jumped to a high of $4.81, its highest point sice mid-November. Despite the jump, the stock has crashed by over 98% this year and is almost 100% below its all-time […]